Standout Papers
Immediate Impact
3 by Nobel laureates 7 from Science/Nature 65 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Works of J. Rodríguez being referenced
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
2023 Standout
A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC): DESTINY-CRC01.
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Rodríguez | 286 | 350 | 246 | 422 | 83 | 1.7k | |
| Kenneth McCormick | 457 | 93 | 215 | 527 | 91 | 2.1k | |
| T. Yamamoto | 431 | 174 | 205 | 458 | 111 | 2.0k | |
| Bogdan Marek | 443 | 198 | 93 | 467 | 160 | 1.9k | |
| Seiki Ito | 467 | 138 | 141 | 348 | 121 | 2.1k | |
| Sirkka-Liisa Karonen | 389 | 204 | 160 | 739 | 44 | 1.9k | |
| Oliver Blankenstein | 514 | 138 | 98 | 1098 | 86 | 2.0k | |
| Stefano Giannini | 676 | 471 | 196 | 585 | 49 | 2.2k | |
| Dariusz Kajdaniuk | 393 | 181 | 93 | 400 | 131 | 1.7k | |
| Jamshid Alaghband‐Zadeh | 357 | 200 | 120 | 481 | 72 | 1.7k | |
| Peter Heinz‐Erian | 707 | 209 | 135 | 200 | 68 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...